Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN955169 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Transcription Factor AP-4 (Activating Enhancer Binding Protein 4) (TFAP4) (AA 132-162), (Middle Region) antibody
- Antibody type
- Polyclonal
- Antigen
- KLH conjugated synthetic peptide between 132-162 amino acids from the Central region of human TFAP4
- Description
- Protein A column followed by peptide affinity purification
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- AA 132-162,Middle Region
- Vial size
- 0.4 mL
- Concentration
- 0.25 mg/mL
- Storage
- Store at 2 - 8°C for up to six months or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Complementary quantitative proteomics reveals that transcription factor AP-4 mediates E-box-dependent complex formation for transcriptional repression of HDM2.
Upregulation of activator protein-4 in human colorectal cancer with metastasis.
AP4 encodes a c-MYC-inducible repressor of p21.
Transfer-NMR and docking studies identify the binding of the peptide derived from activating transcription factor 4 to protein ubiquitin ligase beta-TrCP. Competition STD-NMR with beta-catenin.
Phosphopeptide enrichment by aliphatic hydroxy acid-modified metal oxide chromatography for nano-LC-MS/MS in proteomics applications.
Ku WC, Chiu SK, Chen YJ, Huang HH, Wu WG, Chen YJ
Molecular & cellular proteomics : MCP 2009 Sep;8(9):2034-50
Molecular & cellular proteomics : MCP 2009 Sep;8(9):2034-50
Upregulation of activator protein-4 in human colorectal cancer with metastasis.
Cao J, Tang M, Li WL, Xie J, Du H, Tang WB, Wang H, Chen XW, Xiao H, Li Y
International journal of surgical pathology 2009 Feb;17(1):16-21
International journal of surgical pathology 2009 Feb;17(1):16-21
AP4 encodes a c-MYC-inducible repressor of p21.
Jung P, Menssen A, Mayr D, Hermeking H
Proceedings of the National Academy of Sciences of the United States of America 2008 Sep 30;105(39):15046-51
Proceedings of the National Academy of Sciences of the United States of America 2008 Sep 30;105(39):15046-51
Transfer-NMR and docking studies identify the binding of the peptide derived from activating transcription factor 4 to protein ubiquitin ligase beta-TrCP. Competition STD-NMR with beta-catenin.
Pons J, Evrard-Todeschi N, Bertho G, Gharbi-Benarous J, Tanchou V, Benarous R, Girault JP
Biochemistry 2008 Jan 8;47(1):14-29
Biochemistry 2008 Jan 8;47(1):14-29
Phosphopeptide enrichment by aliphatic hydroxy acid-modified metal oxide chromatography for nano-LC-MS/MS in proteomics applications.
Sugiyama N, Masuda T, Shinoda K, Nakamura A, Tomita M, Ishihama Y
Molecular & cellular proteomics : MCP 2007 Jun;6(6):1103-9
Molecular & cellular proteomics : MCP 2007 Jun;6(6):1103-9
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- TFAP4 Antibody (Center) (AP54225PU-N) western blot analysis in 293 cell line lysates (35 μg/lane). This demonstrates the TFAP4 antibody detected the TFAP4 protein (arrow).
